Evidence map›Paper›PMID 34589381›Full record

ArticleJournal of kidney cancer and VHL2021

Histological Tracking into the Third Dimension: Evolution of Early Tumorigenesis in VHL Kidney.

Mayyan Mubarak, Nayef Al-Gharaibeh, Samuel Sommaruga, Jie Li, Alexander Oliver Vortmeyer

Open access · diamondAbstract read
In one paragraph

Article in Journal of kidney cancer and VHL, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 5 countries.

Mayyan MubarakDepartment of Anesthesiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Nayef Al-GharaibehDepartment of Pathology, Indiana University Purdue University Indianapolis, IN, USA.
Samuel SommarugaDepartment of Medicine, University of Geneva, Switzerland.
Jie LiTianjin Key Laboratory of Clinical Multi-omics, Tianjin, China.
Alexander Oliver VortmeyerDepartment of Pathology, Indiana University Purdue University Indianapolis, IN, USA.
Indiana University – Purdue University Indianapolis · USJordan University of Science and Technology · JOKing Faisal Specialist Hospital & Research Centre · SATianjin University · CNUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using a novel three-dimensional (3D) approach, we tracked histological changes to elucidate the earliest stages of renal clear cell neoplasia in normal kidney tissue of patients with von Hippel-Lindau (VHL) disease. Tissue blocks of interest were procured, serially sectioned, and 3D reconstruction of the entirety of pathologic events was performed. The results reveal an abundance of foci with aberrant clear cell proliferation that initially develop along the tubular lining, but have the potential to aggregate within individual tubules. This stage is followed by the extension of clear cell aggregates beyond the tubular basement membrane, which allows for the recruitment of angiogenesis derived from interstitial vasculature. The results suggest that the most frequent pathologic event in VHL kidneys is the presence of isolated or aggregated clear cells within the tubular epithelium, potentially developing further into a protracted process of neoplasia. The abundance of independent pathologic events in VHL kidneys confirms developmental mechanisms to precede tumor initiation. To our knowledge, this is the first report demonstrating that tracking of histologic changes in the 3rd dimension enables the confirmation of the sequence of events from the earliest pathologic change in the VHL kidney to the neoplastic stage. This approach is not only useful for visualization and quantification of pathologic changes but also for targeted sampling allowing selective analysis of the earliest stages of clear cell carcinogenesis.

Indexed as

carcinogenesisclear cellrenal clear cell carcinomaVHL

Identifiers

PMID34589381
PMCPMC8435883
OpenAlexW3196537753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.